Although seeing a partnership with a BP is highly unlikely, I don't see it as being completely out of the picture. If a BP really believes in the science and the results before the phase IIb study, they might/could do something creative and create a joint venture to see Bavi through to completion. There would be ways that the BP could protect themselves while PPHM is in litigation such as joint venture insurance. I'm not sure...just thinking out loud.
I agree someone was buying big... but I just hope this isn't bigger than Peregrine is up to task or can handle.
Isn't it odd how the recent announcement for a join venture of 10 large BP's and they are all going to be investing money as a group to speed up advancements within the oncology field.
How interesting would it be if many smaller <5% owners popped up (oh wait... we wouldn't officially know because we're only informed with anyone owning over 5% ) .... and down the road when a buyout is worked out... a BP was actually paying back the smaller BP's that needed to invest in the joint venture and now all funds are directed towards the "honey pot" of the 10 BP joint venture where they could own Bavi under their belt and add Bavi to their oncology patent cliff drug busters and see how good it improves their current patented drug and reapply for new patents with the additive of Bavituximab and extend the patent cliff out for another 20 years.
Lots of big assumptions made here... but this is why BP's have people are on the payroll to think outside the box and I certainly hope Peregrine can find one of those thinkers for them at this moment. All I know is its highly likely that someone in the know or directed agendas could have a large position in the company or many smaller positions that we may not find out about without some DD.
I look forward to some additional statements about this law suit... along with with SEC filings shortly.
News 
Market Data 
Discover 
AI
